Insiders · ENTX

ENTX insider transactions

Entera Bio Ltd. (ENTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ENTX

• 31d
  Chief Operating Officer Galitzer Hillel was granted 72,993 units of Ordinary Shares, increasing direct ownership by 81% to 163,566 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 31d
  Chief Financial Officer Yaacov-Garbeli Dana was granted 58,394 units of Ordinary Shares (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 31d
  Chief of R&D Burshtein Gregory was granted 87,591 units of Ordinary Shares, increasing direct ownership by 86% to 189,033 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 89d
  Director Germano Geno J bought $26,000 worth of Ordinary Shares (20,000 units at $1.30), increasing direct ownership by 100% to 40,000 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 91d
  Director Ellis Sean bought $12,300 worth of Ordinary Shares (10,000 units at $1.23), increasing direct ownership by 6% to 188,098 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 111d
  Director Rubin Steven D bought $7,450 worth of Ordinary Shares (5,000 units at $1.49), increasing direct ownership by 50% to 15,000 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 117d
  Director Taitel Haya bought $11,100 worth of Ordinary Shares (7,500 units at $1.48), increasing direct ownership by 8% to 98,479 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 117d
  Director Germano Geno J bought $29,800 worth of Ordinary Shares (20,000 units at $1.49) (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 117d
  Director Rubin Steven D bought $12,000 worth of Ordinary Shares (10,000 units at $1.20) (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 117d
  Director Ellis Sean bought $22,320 worth of Ordinary Shares (18,000 units at $1.24), increasing direct ownership by 11% to 178,098 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 119d
  SEC Form 3 filed by new insider Germano Geno J

  3 - Entera Bio Ltd. (0001638097) (Issuer)
• 123d
  SEC Form 3 filed by new insider Rubin Steven D

  3 - Entera Bio Ltd. (0001638097) (Issuer)
• 157d
  Director Ostrov Gerald M was granted 28,721 units of Ordinary Shares, increasing direct ownership by 61% to 75,657 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 157d
  Director Ellis Sean was granted 25,371 units of Ordinary Shares, increasing direct ownership by 19% to 160,098 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 157d
  Director Malca Yonatan was granted 30,157 units of Ordinary Shares, increasing direct ownership by 64% to 77,416 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 157d
  Director Lieberman Gerald M was granted 38,294 units of Ordinary Shares, increasing direct ownership by 13% to 338,454 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 157d
  Director Taitel Haya was granted 26,329 units of Ordinary Shares, increasing direct ownership by 41% to 90,979 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 160d
  Chief Executive Officer Toledano Miranda Jayne bought $19,912 worth of Ordinary Shares (11,000 units at $1.81), increasing direct ownership by 3% to 426,575 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 325d
  Chief Executive Officer Toledano Miranda Jayne was granted 180,702 units of Ordinary Shares, increasing direct ownership by 77% to 415,575 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 325d
  Chief of R&D Burshtein Gregory was granted 26,316 units of Ordinary Shares, increasing direct ownership by 35% to 101,442 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 325d
  Chief Financial Officer Yaacov-Garbeli Dana was granted 26,316 units of Ordinary Shares (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 384d
  SEC Form 3 filed by new insider Gautam Leslie Velka

  3 - Entera Bio Ltd. (0001638097) (Issuer)
• 404d
  Chief Operating Officer Galitzer Hillel was granted 26,316 units of Ordinary Shares, increasing direct ownership by 41% to 90,573 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 431d
  Director Lieberman Gerald M exercised 23,952 units of Ordinary Shares at a strike of $1.00, increasing direct ownership by 9% to 300,160 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 507d
  Director Taitel Haya was granted 6,922 units of Ordinary Shares, increasing direct ownership by 12% to 64,650 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 507d
  Director Ostrov Gerald M was granted 8,038 units of Ordinary Shares, increasing direct ownership by 21% to 46,936 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 507d
  Director Malca Yonatan was granted 8,216 units of Ordinary Shares, increasing direct ownership by 21% to 47,259 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 507d
  Director Lieberman Gerald M was granted 10,717 units of Ordinary Shares, increasing direct ownership by 4% to 276,208 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 507d
  Director Ellis Sean was granted 7,100 units of Ordinary Shares, increasing direct ownership by 6% to 134,727 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 565d
  New insider Knoll Capital Management, Llc claimed ownership of 5,534,275 units of Ordinary Shares (SEC Form 3)

  3 - Entera Bio Ltd. (0001638097) (Issuer)
• 612d
  Director Taitel Haya was granted 7,278 units of Ordinary Shares, increasing direct ownership by 14% to 57,728 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 612d
  Director Ostrov Gerald M was granted 8,452 units of Ordinary Shares, increasing direct ownership by 28% to 38,898 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 612d
  Director Malca Yonatan was granted 8,639 units of Ordinary Shares, increasing direct ownership by 28% to 39,043 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 612d
  Director Lieberman Gerald M was granted 11,269 units of Ordinary Shares, increasing direct ownership by 4% to 265,491 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 612d
  Director Ellis Sean was granted 7,466 units of Ordinary Shares, increasing direct ownership by 6% to 127,627 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 648d
  Director Ostrov Gerald M was granted 20,446 units of Ordinary Shares, increasing direct ownership by 204% to 30,446 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 648d
  Director Taitel Haya was granted 15,335 units of Ordinary Shares, increasing direct ownership by 44% to 50,450 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 648d
  Director Ellis Sean was granted 18,061 units of Ordinary Shares, increasing direct ownership by 18% to 120,161 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 648d
  Director Malca Yonatan was granted 23,172 units of Ordinary Shares, increasing direct ownership by 320% to 30,404 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 648d
  Director Lieberman Gerald M was granted 27,261 units of Ordinary Shares, increasing direct ownership by 12% to 254,222 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 675d
  Amendment: Chief Financial Officer Yaacov-Garbeli Dana was granted 30,151 units of Ordinary Shares (SEC Form 4)

  4/A - Entera Bio Ltd. (0001638097) (Issuer)
• 675d
  Chief Executive Officer Toledano Miranda Jayne was granted 124,121 units of Ordinary Shares, increasing direct ownership by 112% to 234,873 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 731d
  New insider Burshtein Gregory claimed ownership of 75,126 units of Ordinary Shares (SEC Form 3)

  3 - Entera Bio Ltd. (0001638097) (Issuer)
• 776d
  Yaacov-Garbeli Dana was granted 30,151 units of Ordinary Shares, increasing direct ownership by 53% to 86,731 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 776d
  Galitzer Hillel was granted 30,151 units of Ordinary Shares, increasing direct ownership by 88% to 64,257 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 874d
  Taitel Haya bought $9,405 worth of Ordinary Shares (9,500 units at $0.99), increasing direct ownership by 37% to 35,115 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 879d
  Taitel Haya bought $5,864 worth of Ordinary Shares (7,615 units at $0.77), increasing direct ownership by 42% to 25,615 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 887d
  SEC Form 4 filed by Taitel Haya

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 887d
  SEC Form 4 filed by Garceau Roger

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 887d
  SEC Form 4 filed by Malca Yonatan

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 887d
  SEC Form 4 filed by Ostrov Gerald M

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 887d
  SEC Form 4 filed by Mayron Ron

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 887d
  SEC Form 4 filed by Lieberman Gerald M

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 887d
  SEC Form 4 filed by Ellis Sean

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 894d
  Lieberman Gerald M bought $17,006 worth of Ordinary Shares (23,952 units at $0.71), increasing direct ownership by 12% to 226,961 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 894d
  Toledano Miranda Jayne bought $17,006 worth of Ordinary Shares (23,952 units at $0.71), increasing direct ownership by 28% to 110,752 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 998d
  SEC Form 4 filed by Taitel Haya

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 998d
  SEC Form 4 filed by Toledano Miranda Jayne

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 1019d
  SEC Form 4: Taitel Haya bought $11,216 worth of Ordinary Shares (18,000 units at $0.62)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 1019d
  SEC Form 3 filed by new insider Taitel Haya

  3 - Entera Bio Ltd. (0001638097) (Issuer)